文献速递甲状腺疾病

全球185国15-39岁青少年和年轻成人甲状腺癌的流行病学研究

Thyroid cancer in adolescents and young adults: a population-based study in 185 countries worldwide.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-11-19

该研究基于五大洲癌症发病率数据库和WHO死亡率数据库,分析15-39岁青少年和年轻成人(AYA)甲状腺癌的发病与死亡趋势,并从GLOBOCAN获取185国2022年数据。作者认为流行病学特征提示过度诊断向年轻人群扩展,需减少不必要诊疗。

要点

  • AYA甲状腺癌发病率多数国家快速上升,死亡率稳定低位
  • 发病率与HDI强正相关,提示过度诊断向年轻人群扩展

核心结论

  • AYA甲状腺癌流行病学特征提示过度诊断已扩展至年轻人群,需防止诊断程序过度使用带来的不必要诊疗。

研究设计与样本

  • 基于五大洲癌症发病率Plus数据库和WHO死亡率数据库的群体研究,趋势分析覆盖2003-2017年,185国2022年发病与死亡估计来自GLOBOCAN平台。

主要发现

  • 多数国家AYA甲状腺癌发病率自2000年代以来快速上升,而死亡率保持稳定低位。
  • 韩国、塞浦路斯、厄瓜多尔和土耳其发病率上升显著,中国上升尤为明显。
  • 2003-2017年间甲状腺癌发病率年均百分比变化在6国大于10%、在19国大于5%。

关键数值与推荐

  • 部分国家AYA甲状腺癌发病死亡比女性超过3300、男性超过600,而其他癌种低于100。
  • HDI与甲状腺癌发病率呈强正相关,与死亡率呈负相关但较弱。

临床怎么用

  • 对AYA甲状腺癌应警惕过度诊断,避免诊断程序过度使用导致的不必要诊断和治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cancer burden among adolescents and young adults (AYAs) aged 15-39 years has increased during the past two decades, with thyroid cancer being a major contributor. We aimed to comprehensively evaluate trends and the current burden of thyroid cancer among AYAs globally. METHODS: We obtained annual incidence and mortality data of thyroid cancer from the Cancer Incidence in Five Continents Plus and the WHO Mortality databases. Temporal trends were displayed using the average annual percent changes of age-standardised incidence rates estimated during 2003-2017. The national estimates of incidence and mortality of thyroid cancer and other cancer types for 185 countries in 2022 were obtained from the GLOBOCAN platform. Incidence-to-mortality ratios were compared by cancer type. We estimated the correlation of human development index (HDI) with thyroid cancer incidence and mortality. FINDINGS: Thyroid cancer incidence rates among AYAs have increased rapidly since the 2000s in most countries, whereas mortality rates remained stably low. Notable increases in incidence were found in South Korea, Cyprus, Ecuador, and Türkiye, with particularly pronounced rises in China. During 2003-2017, the average annual percent changes of thyroid cancer incidence were greater than 10% in six countries and greater than 5% in 19 countries. In 2022, there were approximately 237 000 new cases and around 2100 deaths from thyroid cancer, ranking among the top three most diagnosed cancers in 100 countries for females and in 26 countries for males. By 2022, thyroid cancer accounted for 20·3% of all new cancer cases in female AYAs and 13·6% in male AYAs, ranking as the second most diagnosed cancer among female AYAs, after breast cancer, and the most common cancer among male AYAs. Thyroid cancer incidence rates varied greatly by country, continent, and HDI, while mortality rates were less variable. The incidence-to-mortality ratios for thyroid cancer among AYAs exceeded 3300 for females and 600 for males (<100 for other cancer types) in some countries. HDI was strongly and positively correlated with thyroid cancer incidence, whereas its association with mortality was negative but weak. INTERPRETATION: The epidemiological profile of thyroid cancer among AYAs indicates a large expansion of overdiagnosis to younger populations. Increased efforts are required to prevent unnecessary diagnosis and treatment due to overuse of diagnostic procedures. FUNDING: Guangzhou Science and Technology Project, Guangdong Basic and Applied Basic Research Foundation, Italian Association for Cancer Research, Italian Ministry of Health, and Young Talents Program of Sun Yat-sen University Cancer Center.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Li M, Dal Maso L, Pizzato M, et al. Thyroid cancer in adolescents and young adults: a population-based study in 185 countries worldwide. Lancet Diabetes Endocrinol. 2025. PMID: 41274302. doi:10.1016/S2213-8587(25)00289-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。